Merck acquires digital technology company in $2.4-billion deal

The investment is intended to help veterinarians gain access to real-time, actionable information to improve livestock management and health outcomes

Suggested Veterinary Products

Merck Animal Health has signed a $2.4-billion (€2.1-billion) agreement it says will help increase the use of digital technology in animal agriculture.

Under this deal, Merck will acquire Antelliq Group, a digital animal identification, traceability, and monitoring company.

Antelliq’s products allow access to real-time, actionable information that can help farmers and veterinarians improve livestock management and health outcomes.

As part of the agreement, Merck will make a cash payment of nearly $2.4 billion (€2.1 billion) to obtain all outstanding shares of Antelliq and will assume the company’s debt of $1.3 billion (€1.15 billion), which it intends to repay shortly after the closing of the acquisition.

“The animal health industry is rapidly evolving with revolutionary digital solutions to manage the health and well-being of livestock and companion animals,” said Rick DeLuca, president of Merck Animal Health.

“Animal identification, monitoring, and smart data management are critical components of this transformative technology.”

Antelliq will be a wholly owned and separately operated subsidiary within the Merck Animal Health Division.


Leave a Comment


Your email address will not be published. Required fields are marked *


Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.